Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Serum miR-20a and miR-486 are potential biomarkers for discriminating colorectal neoplasia: A pilot study

Yang Qinglan, Wang Shuiming, Huang Jianfeng, Xia Chengwan, Jin Heiying, Fan Yimei

Year : 2018| Volume: 14| Issue : 7 | Page no: 1572-1577

   This article has been cited by
1 Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update
Adil A. Sayyed, Piyush Gondaliya, Palak Bhat, Mukund Mali, Neha Arya, Amit Khairnar, Kiran Kalia
Current Pharmaceutical Design. 2022; 28(6): 471
[Pubmed]  [Google Scholar] [DOI]
2 Investigating the Role of Circulating miRNAs as Biomarkers in Colorectal Cancer: An Epidemiological Systematic Review
Lucia Dansero, Fulvio Ricceri, Laura De Marco, Valentina Fiano, Ginevra Nesi, Lisa Padroni, Lorenzo Milani, Saverio Caini, Giovanna Masala, Claudia Agnoli, Carlotta Sacerdote
Biomedicines. 2022; 10(9): 2224
[Pubmed]  [Google Scholar] [DOI]
3 MicroRNAs and ‘Sponging’ Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets
Brian G. Jorgensen, Seungil Ro
International Journal of Molecular Sciences. 2022; 23(4): 2166
[Pubmed]  [Google Scholar] [DOI]
4 miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling
Cao Sha, Gao Jia, Zhao Jingjing, Hu Yapeng, Lou Zhi, Xu Guanghui
Naunyn-Schmiedeberg's Archives of Pharmacology. 2021; 394(1): 177
[Pubmed]  [Google Scholar] [DOI]
5 Function and mechanisms of microRNA-20a in colorectal cancer (Review)
Zheng Xiao, Shi Chen, Shujun Feng, Yukun Li, Juan Zou, Hui Ling, Ying Zeng, Xi Zeng
Experimental and Therapeutic Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article